Literature DB >> 20033221

The IGF/IGFBP system in relation to macroscopic bone architecture in pediatric renal transplant patients.

Daniela Kiepe1, Eva-Maria Rüth, Werner F Blum, Subburaman Mohan, Lutz T Weber, Burkhard Tönshoff.   

Abstract

The post-transplant bone disease of the peripheral skeleton in pediatric renal transplant recipients is characterized by an inadequately thin bone cortex in relation to muscular force. A major hormonal modulator of periosteal growth is the insulin-like growth factor (IGF)/IGF binding protein (IGFBP) system. We therefore hypothesized that the reduced cortical thickness in these patients may be due to functional IGF deficiency. To test this hypothesis, we investigated 55 patients (mean estimated glomerular filtration rate 86.3 +/- 30.0 ml/min/1.73 m(2)) in a cross-sectional study. Parameters of macroscopic bone architecture and forearm muscle size were analyzed by peripheral quantitative computed tomography (pQCT), and serum IGF/IGFBP system components were measured by specific radioimmunoassays. The mean (+/- standard deviation) standardized serum IGF-I (0.20 +/- 1.16 score) level was normal, while the mean IGF-II (1.16 +/- 0.11 score) level was significantly elevated. Serum IGFBP-1 and IGFBP-2 levels were not altered, whereas the IGFBP-3 (1.34 +/- 0.15 score) level was significantly increased. The serum IGFBP-4 level was slightly elevated (by 11%), the IGFBP-6 level was markedly (2.3-fold) elevated, while the IGFBP-5 level was comparable to that of the control. The respective age-adjusted cortical thickness at both the proximal (r = 0.407, P < 0.005) and distal (r = 0.383, P < 0.01) forearm was positively correlated with the standardized serum IGF-I level. In conclusion, the serum IGF/IGFBP system in pediatric renal transplant recipients is characterized by an increase in the levels of the inhibitory IGFBPs, IGFBP-3, -4 and -6, resulting in a functional IGF deficiency. The positive correlation of IGF-I with cortical thickness underlines the importance of this hormonal system in the modeling of bone, particularly periosteal growth.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20033221     DOI: 10.1007/s00467-009-1405-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  45 in total

1.  Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2).

Authors:  Yousef G Amaar; Garrett R Thompson; Thomas A Linkhart; Shin-Tai Chen; David J Baylink; Subburaman Mohan
Journal:  J Biol Chem       Date:  2002-01-30       Impact factor: 5.157

2.  Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development.

Authors:  A Prader; R H Largo; L Molinari; C Issler
Journal:  Helv Paediatr Acta Suppl       Date:  1989-06

3.  Impaired skeletal growth in mice with haploinsufficiency of IGF-I: genetic evidence that differences in IGF-I expression could contribute to peak bone mineral density differences.

Authors:  S Mohan; D J Baylink
Journal:  J Endocrinol       Date:  2005-06       Impact factor: 4.286

4.  Modeling of cross-sectional bone size, mass and geometry at the proximal radius: a study of normal bone development using peripheral quantitative computed tomography.

Authors:  C M Neu; F Rauch; F Manz; E Schoenau
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

Review 5.  Bone disease after renal transplantation.

Authors:  James G Heaf
Journal:  Transplantation       Date:  2003-02-15       Impact factor: 4.939

Review 6.  Growth hormone/insulin-like growth factor system in children with chronic renal failure.

Authors:  Burkhard Tönshoff; Daniela Kiepe; Sonia Ciarmatori
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

7.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

8.  Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.

Authors:  P Bang; M Degerblad; M Thorén; J Schwander; W Blum; K Hall
Journal:  Acta Endocrinol (Copenh)       Date:  1993-05

9.  Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.

Authors:  A C Hokken-Koelega; T Stijnen; S M de Muinck Keizer-Schrama; W F Blum; S L Drop
Journal:  J Clin Endocrinol Metab       Date:  1993-10       Impact factor: 5.958

10.  An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone.

Authors:  V Nicolas; S Mohan; Y Honda; A Prewett; R D Finkelman; D J Baylink; J R Farley
Journal:  Calcif Tissue Int       Date:  1995-09       Impact factor: 4.333

View more
  2 in total

Review 1.  Growth hormone improves growth in pediatric renal transplant recipients--a systemic review and meta-analysis of randomized controlled trials.

Authors:  Yang Wu; Wei Cheng; Xiao-Dong Yang; Bo Xiang
Journal:  Pediatr Nephrol       Date:  2012-06-04       Impact factor: 3.714

2.  Bone density and cortical structure after pediatric renal transplantation.

Authors:  Anniek M Terpstra; Heidi J Kalkwarf; Justine Shults; Babette S Zemel; Rachel J Wetzsteon; Bethany J Foster; C Frederic Strife; Debbie L Foerster; Mary B Leonard
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.